Correlation Between Pfizer and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pfizer and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Crispr Therapeutics AG, you can compare the effects of market volatilities on Pfizer and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Crispr Therapeutics.
Diversification Opportunities for Pfizer and Crispr Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Pfizer and Crispr is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Pfizer and Crispr Therapeutics
Considering the 90-day investment horizon Pfizer is expected to generate 5.9 times less return on investment than Crispr Therapeutics. But when comparing it to its historical volatility, Pfizer Inc is 1.39 times less risky than Crispr Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 5,565 in Crispr Therapeutics AG on March 12, 2024 and sell it today you would earn a total of 222.00 from holding Crispr Therapeutics AG or generate 3.99% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Crispr Therapeutics AG
Performance |
Timeline |
Pfizer Inc |
Crispr Therapeutics |
Pfizer and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Crispr Therapeutics
The main advantage of trading using opposite Pfizer and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.Pfizer vs. Johnson Johnson | Pfizer vs. Gfl Environmental Holdings | Pfizer vs. Gold Fields Ltd | Pfizer vs. OReilly Automotive |
Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Transaction History View history of all your transactions and understand their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |